SARS-CoV2 Omicron XBB.1.5 variant specific RBD/NTD-peptide library: The current XBB variant of SARS-CoV-2 with the strongest immune escaping properties is currently the most dominant variant circulating around the world. It is highly required to delineate the binding capabilities of NTD of XBB subvariant towards human neutralizing antibodies and to dig out the binding affinity of RBD of XBB subvariant with ACE2 receptor. The SARS-CoV-2 Receptor Binding Domain is divided in to several fragments (20-30 amino acids) that with or without overlap (5 amino acids). The resulting overlapping peptide libraries can then be used for processes including continuous and linear epitope mapping, antibody screening and characterization.
LifeTein can help in your research with custom peptide synthesis of the following specific proteins: SARS-CoV-2 Receptor Binding Domains, SARS-CoV-2 Nucleocapsid Fragments, T-cell and B-cell Epitopes of SARS-CoV-2, Fusion Inhibitors Targeting HR1 Domain of the SARS-CoV-2 Spike Proteins, Inhibitors of SARS-CoV-2 Mpro/3CLpro/C30 Endopeptidase, ACE2 Inhibitors and Substrates, and AT2 Receptor Agonists and Antagonists.
Pool of 17 biotinylated peptides derived from a peptide design through the receptor binding domain of XBB.1.5NTD.
Modifications: N-Terminal: Biotin Labeling
Amount: 1mg per peptide
Purity: 95%
Delivery Format: Freeze dried powder
Application(s): Antibody screening, T-cell assays, Immune monitoring, antigen-specific T-cell stimulation, Cellular immune response
Indication(s)/Topic(s): Covid-19, Infection, Respiratory infection
Delivery Time: In Stock
SARS-CoV-2 Receptor Binding Domains Peptide Pools:
QCVNLITRTQSYTNSFTRGV
FSNVTWFHAIHVSGTNGTKRFDNPAL
CNDPFLDVYQKNNKSWMESEFRVYSSANNC
SQPFLMDLEGKEGNFKNLREF
HTPINLERDLPQGFSAL
DLPIGINITRFQTLLA
SYLTPVDSSSGWTAG
NENGTITDAVDCALDPLS
FTVEKGIYQTSNFRVQ
FPNITNLCPFHEVF
NATTFASVYAWNRKRISNCVA
PFFAFKCYGV
VIRGNEVSQIAPGQTGNIADYNYKLPD
NKLDSKPSGNYNY
LFRKSKLKPFERDISTEIYQAGNKPC
NGVAGPNCYSPLQSYGFRPTYGVGHQP
TVCGPKKSTNLV
